Suchergebnisse - "Antibodies, Monoclonal, Humanized"

PubPharm (9.837)

61

Extended interval dosing of ocrelizumab in patients with multiple sclerosis is not associated with meaningful differences in disease activity

enthalten in: Multiple sclerosis (Houndmills, Basingstoke, England) | 2024

von Bou Rjeily, N. | Fitzgerald, K. | Mowry, E.

62

Mirvetuximab soravtansine in ovarian cancer therapy : expert opinion on pharmacological considerations

enthalten in: Cancer chemotherapy and pharmacology | 2024

von Nwabufo, C.

63

Outcomes with atezolizumab in metastatic urothelial cancer : real-world data from a single institution

enthalten in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | 2024

von Sotelo, M. | Muñoz-Unceta, N. | Matorras, A. | +6

64

Real-World Experience With Teprotumumab in Patients With Dysthyroid Optic Neuropathy

enthalten in: Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society | 2024

von Tamhankar, M. | Pradeep, T. | Chen, Y. | +1

65

Burosumab : Current status and future prospects

enthalten in: Best practice & research. Clinical endocrinology & metabolism | 2024

von Goyal, A. | Tandon, N.

66

Delayed immune-related hepatitis after 24 months of pembrolizumab treatment : a case report and literature review

enthalten in: Anti-cancer drugs | 2024

von Salazar González, F. | Quiñones Palacios, C. | Manzaneque Gordón, A. | +3

67

Surufatinib combined camrelizumab as a valuable third-line rescue therapy for a patient with extensive-stage for small-cell lung cancer : a case report and literature review

enthalten in: Anti-cancer drugs | 2024

von Pan, C. | Yu, T. | Han, L. | +5

68

Sotrovimab : A Review of Its Efficacy against SARS-CoV-2 Variants

enthalten in: Viruses | 2024

von Focosi, D. | Casadevall, A. | Franchini, M. | +1

69

Ranibizumab Biosimilars in Treating Retinal Disorders : A Cost-Effective Revolution?

enthalten in: Drug design, development and therapy | 2024

von Chatzimichail, E. | Pfau, K. | Gatzioufas, Z. | +1

70

Lessons Learned from Approval of Aducanumab for Alzheimer's Disease

enthalten in: Annual review of medicine | 2024

von Heidebrink, J. | Paulson, H.